Globus Medical Statistics
Total Valuation
Globus Medical has a market cap or net worth of $10.01 billion. The enterprise value is $9.59 billion.
| Market Cap | 10.01B |
| Enterprise Value | 9.59B |
Important Dates
The next confirmed earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Globus Medical has 137.54 million shares outstanding. The number of shares has increased by 20.27% in one year.
| Current Share Class | 115.11M |
| Shares Outstanding | 137.54M |
| Shares Change (YoY) | +20.27% |
| Shares Change (QoQ) | +1.19% |
| Owned by Insiders (%) | 16.77% |
| Owned by Institutions (%) | 80.21% |
| Float | 114.22M |
Valuation Ratios
The trailing PE ratio is 97.07 and the forward PE ratio is 21.40. Globus Medical's PEG ratio is 1.88.
| PE Ratio | 97.07 |
| Forward PE | 21.40 |
| PS Ratio | 3.92 |
| Forward PS | 3.69 |
| PB Ratio | 2.39 |
| P/TBV Ratio | 5.14 |
| P/FCF Ratio | 24.71 |
| P/OCF Ratio | 19.23 |
| PEG Ratio | 1.88 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.80, with an EV/FCF ratio of 23.68.
| EV / Earnings | 93.17 |
| EV / Sales | 3.81 |
| EV / EBITDA | 13.80 |
| EV / EBIT | 21.76 |
| EV / FCF | 23.68 |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.54 |
| Quick Ratio | 1.72 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.75 |
| Debt / FCF | 1.33 |
| Interest Coverage | 105.28 |
Financial Efficiency
Return on equity (ROE) is 2.52% and return on invested capital (ROIC) is 5.97%.
| Return on Equity (ROE) | 2.52% |
| Return on Assets (ROA) | 5.33% |
| Return on Invested Capital (ROIC) | 5.97% |
| Return on Capital Employed (ROCE) | 10.03% |
| Revenue Per Employee | $475,350 |
| Profits Per Employee | $19,431 |
| Employee Count | 5,300 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.09 |
Taxes
In the past 12 months, Globus Medical has paid $17.74 million in taxes.
| Income Tax | 17.74M |
| Effective Tax Rate | 14.69% |
Stock Price Statistics
The stock price has increased by +41.72% in the last 52 weeks. The beta is 1.29, so Globus Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | +41.72% |
| 50-Day Moving Average | 75.07 |
| 200-Day Moving Average | 77.02 |
| Relative Strength Index (RSI) | 49.76 |
| Average Volume (20 Days) | 1,127,025 |
Short Selling Information
The latest short interest is 4.24 million, so 3.08% of the outstanding shares have been sold short.
| Short Interest | 4.24M |
| Short Previous Month | 2.42M |
| Short % of Shares Out | 3.08% |
| Short % of Float | 3.71% |
| Short Ratio (days to cover) | 3.20 |
Income Statement
In the last 12 months, Globus Medical had revenue of $2.52 billion and earned $102.98 million in profits. Earnings per share was $0.75.
| Revenue | 2.52B |
| Gross Profit | 1.70B |
| Operating Income | 441.03M |
| Pretax Income | 66.55M |
| Net Income | 102.98M |
| EBITDA | 695.05M |
| EBIT | 441.03M |
| Earnings Per Share (EPS) | $0.75 |
Balance Sheet
The company has $890.06 million in cash and $537.72 million in debt, giving a net cash position of $418.47 million or $3.04 per share.
| Cash & Cash Equivalents | 890.06M |
| Total Debt | 537.72M |
| Net Cash | 418.47M |
| Net Cash Per Share | $3.04 |
| Equity (Book Value) | 4.18B |
| Book Value Per Share | 30.40 |
| Working Capital | 1.32B |
Cash Flow
In the last 12 months, operating cash flow was $520.64 million and capital expenditures -$115.43 million, giving a free cash flow of $405.21 million.
| Operating Cash Flow | 520.64M |
| Capital Expenditures | -115.43M |
| Free Cash Flow | 405.21M |
| FCF Per Share | $2.95 |
Margins
Gross margin is 67.46%, with operating and profit margins of 17.51% and 4.09%.
| Gross Margin | 67.46% |
| Operating Margin | 17.51% |
| Pretax Margin | 4.79% |
| Profit Margin | 4.09% |
| EBITDA Margin | 27.59% |
| EBIT Margin | 17.51% |
| FCF Margin | 16.08% |
Dividends & Yields
Globus Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.27% |
| Shareholder Yield | n/a |
| Earnings Yield | 1.03% |
| FCF Yield | 4.05% |
Analyst Forecast
The average price target for Globus Medical is $96.91, which is 32.94% higher than the current price. The consensus rating is "Buy".
| Price Target | $96.91 |
| Price Target Difference | 32.94% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 7.54% |
| EPS Growth Forecast (5Y) | 49.28% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Globus Medical has an Altman Z-Score of 6.36 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.36 |
| Piotroski F-Score | 5 |